Health Rosetta Group

Health Rosetta Group

Health Rosetta Group emerged from the Health Rosetta ecosystem, a public-benefit initiative Dave Chase launched to codify what high-performing employer health plans do differently. The civic project identified 42 components that drive better outcomes at lower cost; the investment firm applies that same lens to acquire and scale founder-owned healthcare-services businesses. It is structured as a long-duration holding company rather than a traditional 5-to-7-year fund, which allows it to buy companies without the forced exit timeline that characterizes conventional private equity. The firm pursues control buyouts of US-based middle-market companies in revenue-cycle management, third-party benefits administration, and tech-enabled care delivery. It targets businesses with $5 million to $50 million in revenue that are already profitable and need operational sophistication rather than a turnaround. The Health Rosetta certification framework serves a dual purpose: it provides a proprietary sourcing filter for identifying overlooked assets, and it creates a common operational language that acquired portfolio companies use post-close. Dave Chase has publicly stated the firm intends to hold assets indefinitely, aligning itself more with family-office and Berkshire-style ownership than with fund-cycle private equity. As of early 2026, Health Rosetta Group operates from Seattle with a lean central team that supplies shared financial, legal, and technology resources to portfolio companies. The firm has not disclosed total assets under management or aggregate deployment figures. The investment model relies on deal-by-deal capital formation rather than a blind pool, with Chase positioning the vehicle as a vehicle for operators and family offices who want healthcare exposure without the standard PE liquidity pressures. Chase continues to write and speak publicly about the failures of the employer-healthcare purchasing system, which keeps the investment firm tethered to a visible public narrative that also serves as a deal-origination channel. What differentiates Health Rosetta Group structurally is the integration of a public-standards body with a private investment vehicle. The nonprofit Health Rosetta arm provides an independent certification that functions as an underwriting shortcut; the investment firm then acquires companies that meet or can be made to meet that standard. No other healthcare-services buyout shop operates with a publicly documented quality framework that doubles as a deal-sourcing system, which gives the firm a repeatable method for identifying targets that institutional buyers often overlook.